Doctors Note Logo

Published on: 8/18/2026

X-Linked Hypophosphatemia: Getting Diagnosed

Diagnosis of X-linked hypophosphatemia (XLH) usually begins with blood and urine tests showing low serum phosphate, high phosphate loss in the urine, elevated FGF23, and normal or low active vitamin D with normal calcium, followed by X-rays or skeletal imaging that reveal rickets, bowed legs, or osteomalacia. Genetic testing for a PHEX gene mutation confirms the diagnosis, and family history matters because XLH is inherited in an X-linked dominant pattern, though about one in three cases occur with no family history. Because XLH is often mistaken for nutritional rickets, growth delay, or ordinary joint pain, many people wait years for an answer, so specialist referral to an endocrinologist, nephrologist, or geneticist is often the turning point. There are several factors that affect how quickly XLH is identified in children versus adults, and important testing details are explained below.

If you or your child has unexplained bowed legs, short stature, bone or joint pain, dental abscesses, or hearing changes, a free, instant, online symptom check can help you organize your symptoms, see which conditions may fit the pattern, and walk into your next appointment ready to ask for the specific phosphate and genetic tests that lead to a clear diagnosis.

Last reviewed for medical accuracy: 08/18/2026

answer background

Explanation

X-Linked Hypophosphatemia: Getting Diagnosed

X-linked hypophosphatemia (XLH) is a rare inherited disorder that affects the body’s ability to balance phosphate. Phosphate is vital for strong bones, muscle function, and overall health. Early diagnosis of x linked hypophosphatemia helps guide treatment, support growth in children, and reduce long-term complications.

What Is X-Linked Hypophosphatemia?

  • A genetic condition caused by mutations in the PHEX gene, carried on the X chromosome.
  • Leads to low phosphate levels in the blood (hypophosphatemia) despite normal dietary intake.
  • Results in weakened, softened bones (rickets in children; osteomalacia in adults), dental issues, and muscle weakness.
  • Affects males more severely but can also cause symptoms in females.

Why Early Diagnosis Matters

  • Growth and Development: Children with XLH can have bowed legs, short stature, and delayed motor milestones. Starting treatment early supports more normal growth patterns.
  • Bone Health: Untreated hypophosphatemia can lead to chronic bone pain, fractures, and permanent skeletal deformities.
  • Quality of Life: Early recognition and therapy reduce pain, improve mobility, and limit dental complications.
  • Long-Term Outcomes: Timely diagnosis helps prevent complications such as hearing loss, joint disease, and kidney problems.

Common Signs and Symptoms

XLH symptoms can vary by age. Not everyone has every sign, but common features include:

Children

  • Bowed or knock-kneed legs
  • Delayed walking or difficulty running and jumping
  • Shorter height compared to peers
  • Frequent falls or muscle weakness
  • Dental abscesses and cavities

Adults

  • Persistent bone and joint pain
  • Stress fractures, especially in the legs
  • Osteomalacia (softening of bones)
  • Early-onset osteoarthritis
  • Dental problems (weak enamel, abscesses)

Family History

  • A parent with XLH or unexplained rickets/osteomalacia
  • A pattern of similar bone or dental issues in male relatives

How Is X-Linked Hypophosphatemia Diagnosed?

Diagnosis of x linked hypophosphatemia is based on a combination of clinical evaluation, laboratory tests, imaging studies, and genetic testing.

1. Medical History and Physical Exam

  • Review growth charts, developmental milestones, and family history.
  • Examine bone alignment (legs, arms, spine) and dental health.
  • Assess muscle strength and joint range of motion.

2. Blood Tests

Key laboratory values in XLH often include:

  • Low serum phosphate
  • Normal to low serum calcium
  • Elevated alkaline phosphatase (marker of bone turnover)
  • Inappropriately normal or elevated levels of fibroblast growth factor 23 (FGF23), which regulates phosphate

These tests help confirm chronic phosphate wasting rather than dietary deficiency.

3. Urine Tests

  • Measure phosphate excretion over 24 hours.
  • Calculate the tubular maximum for phosphate reabsorption per glomerular filtration rate (TmP/GFR). In XLH, TmP/GFR is low, indicating kidney loss of phosphate.

4. Imaging Studies

  • X-rays of the knees, wrists, or spine can show classic signs of rickets in children (e.g., widened growth plates, bowed bones).
  • In adults, X-rays may reveal osteomalacia-related changes (bone demineralization, pseudofractures).
  • Dental X-rays identify defects in tooth roots and enamel.

5. Genetic Testing

  • DNA analysis to detect mutations in the PHEX gene confirms the diagnosis.
  • Genetic counseling is recommended for families to understand inheritance patterns and reproductive options.

Differentiating XLH from Other Conditions

Other causes of rickets or osteomalacia must be ruled out:

  • Nutritional rickets (vitamin D deficiency)
  • Renal tubular disorders (Fanconi syndrome)
  • Hormonal disorders (hypoparathyroidism)
  • Rare genetic conditions affecting phosphate metabolism

Accurate diagnosis ensures the correct treatment plan.

Next Steps After Diagnosis

Once x linked hypophosphatemia is confirmed, a care plan typically involves:

  • Phosphate Supplements: Taken by mouth several times a day to raise blood phosphate.
  • Active Vitamin D (Calcitriol or Analogues): Helps increase intestinal absorption of calcium and phosphate.
  • Burosumab (if available and approved): A monoclonal antibody targeting excess FGF23, shown to improve phosphate levels and bone health.
  • Orthopedic Monitoring: To evaluate and manage bone deformities; surgery may be needed for severe bowing.
  • Dental Care: Regular exams, fluoride treatments, and prompt treatment of cavities and abscesses.
  • Physical Therapy: To strengthen muscles, improve posture, and support mobility.

Regular follow-up with a multidisciplinary team (endocrinologist, nephrologist, orthopedist, dentist) ensures treatment stays on track.

Monitoring and Long-Term Care

Lifelong monitoring is essential to adjust therapy and detect complications early:

  • Serum phosphate, calcium, alkaline phosphatase every 3–6 months.
  • Kidney ultrasound to check for nephrocalcinosis (calcium deposits).
  • Bone density tests (DXA scans) as recommended.
  • Hearing tests, as hearing loss can occur in adults with XLH.
  • Growth assessments in children at each visit.

When to Seek Immediate Medical Attention

While XLH itself is rarely life-threatening, complications or other symptoms may require urgent care. Speak to a doctor if you or your child experiences:

  • Severe, unrelenting bone or abdominal pain
  • Signs of low calcium (muscle spasms, tingling around lips or hands)
  • Sudden difficulty breathing or swallowing
  • High fever or signs of infection (e.g., dental abscess with swelling and fever)

Anything that feels serious or life-threatening should be evaluated right away by a healthcare professional.

Free, Online Symptom Check

If you’re unsure whether your symptoms fit x linked hypophosphatemia or another condition, you might consider doing a free, online symptom check, using the doctor approved Ubie Symptom Checker. It can help you organize your concerns before speaking with a healthcare provider.

👉 Free, online symptom check, using the doctor approved Ubie Symptom Checker

Talking to Your Doctor

  • Prepare a list of symptoms, family history, and any prior lab results.
  • Ask about the risks and benefits of genetic testing for XLH.
  • Discuss treatment goals, side effects, and how often to follow up.
  • Bring up any concerns about growth, pain, or dental issues.

Always consult your doctor for anything serious or life-threatening. Early diagnosis and a solid care plan can make a significant difference in managing x linked hypophosphatemia and maintaining a good quality of life.

(References)

  • * Baroncelli GI, Toschi B, Bertelloni S. Hypophosphatemic rickets. Curr Opin Endocrinol Diabetes Obes. 2012 Dec;19(6):460-7. doi: 10.1097/MED.0b013e328358be97. PMID: 23108197.

  • * Haffner D, Emma F, Eastwood DM, Biosse Duplan M, Bacchetta J, Schnabel D, Wicart P, Bockenhauer D, Santos F, Levtchenko E, Harvengt P, Kirchhoff M, Di Rocco F, Chaussain C, Brandi ML, Savendahl L, Briot K, Kamenicky P, Rejnmark L, Linglart A. Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia. Nat Rev Nephrol. 2019 Jul;15(7):435-455. doi: 10.1038/s41581-019-0152-5. PMID: 31068690; PMCID: PMC7136170.

  • * Imel EA, Glorieux FH, Whyte MP, Munns CF, Ward LM, Nilsson O, Simmons JH, Padidela R, Namba N, Cheong HI, Pitukcheewanont P, Sochett E, Högler W, Muroya K, Tanaka H, Gottesman GS, Biggin A, Perwad F, Mao M, Chen CY, Skrinar A, San Martin J, Portale AA. Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial. Lancet. 2019 Jun 15;393(10189):2416-2427. doi: 10.1016/S0140-6736(19)30654-3. Epub 2019 May 16. PMID: 31104833; PMCID: PMC7179969.

  • * Rush ET, Johnson B, Aradhya S, Beltran D, Bristow SL, Eisenbeis S, Guerra NE, Krolczyk S, Miller N, Morales A, Ramesan P, Sarafrazi S, Truty R, Dahir K. Molecular Diagnoses of X-Linked and Other Genetic Hypophosphatemias: Results From a Sponsored Genetic Testing Program. J Bone Miner Res. 2022 Feb;37(2):202-214. doi: 10.1002/jbmr.4454. Epub 2021 Nov 10. PMID: 34633109; PMCID: PMC9298723.

  • * Chinoy A, Padidela R. Refractory Rickets. Indian J Pediatr. 2023 Jun;90(6):574-581. doi: 10.1007/s12098-023-04538-4. Epub 2023 Apr 19. PMID: 37074534; PMCID: PMC10212799.

  • * Ito N, Hidaka N, Kato H. The pathophysiology of hypophosphatemia. Best Pract Res Clin Endocrinol Metab. 2024 Mar;38(2):101851. doi: 10.1016/j.beem.2023.101851. Epub 2023 Nov 30. PMID: 38087658.

  • * Haffner D, Emma F, Seefried L, Högler W, Javaid KM, Bockenhauer D, Bacchetta J, Eastwood D, Biosse Duplan M, Schnabel D, Wicart P, Ariceta G, Levtchenko E, Harvengt P, Kirchhoff M, Gardiner O, Di Rocco F, Chaussain C, Brandi ML, Savendahl L, Briot K, Kamenický P, Rejnmark L, Linglart A. Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia. Nat Rev Nephrol. 2025 May;21(5):330-354. doi: 10.1038/s41581-024-00926-x. Epub 2025 Jan 15. PMID: 39814982.

  • * Ali DS, Carpenter TO, Imel EA, Ward LM, Appelman-Dijkstra NM, Chaussain C, Jan de Beur SM, Florenzano P, Abu Alrob H, Aldabagh R, Alexander RT, Alsarraf F, Beck-Nielsen SS, Biosse-Duplan M, Crowley RK, Dandurand K, Filler G, Friedlander L, Fukumoto S, Gagnon C, Goodyer P, Grasemann C, Grimbly C, Hussein S, Javaid MK, Khan S, Khan A, Lehman A, Lems WF, Lewiecki EM, McDonnell C, Mirza RD, Morgante E, Morrison A, Portale AA, Rao C, Rhee Y, Rush ET, Siggelkow H, Tetradis S, Tosi L, Guyatt G, Brandi ML, Khan AA. X-Linked Hypophosphatemia Management in Children: An International Working Group Clinical Practice Guideline. J Clin Endocrinol Metab. 2025 Jun 17;110(7):2055-2070. doi: 10.1210/clinem/dgaf093. PMID: 39960858; PMCID: PMC12187519.

  • * Khan AA, Ali DS, Appelman-Dijkstra NM, Carpenter TO, Chaussain C, Imel EA, Jan de Beur SM, Florenzano P, Abu Alrob H, Aldabagh R, Alexander RT, Alsarraf F, Beck-Nielsen SS, Biosse-Duplan M, Cohen-Solal M, Crowley RK, Dandurand K, Filler G, Friedlander L, Fukumoto S, Gagnon C, Goodyer P, Grasemann C, Grimbly C, Hussein S, Javaid MK, Khan S, Khan A, Lehman A, Lems WF, Lewiecki EM, McDonnell C, Mirza RD, Morgante E, Morrison A, Portale AA, Rhee Y, Rush ET, Siggelkow H, Tetradis S, Tosi L, Ward LM, Guyatt G, Brandi ML. X-Linked Hypophosphatemia Management in Adults: An International Working Group Clinical Practice Guideline. J Clin Endocrinol Metab. 2025 Jul 15;110(8):2353-2370. doi: 10.1210/clinem/dgaf170. PMID: 40243526; PMCID: PMC12261105.

  • * Böckmann I, Haffner D. The Diagnosis and Therapy of XLH. Calcif Tissue Int. 2025 Apr 28;116(1):66. doi: 10.1007/s00223-025-01374-w. Epub 2025 Apr 28. PMID: 40295317; PMCID: PMC12037658.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.